Greenup Street Wealth Management LLC Purchases 6,354 Shares of Intuitive Surgical, Inc. $ISRG

by · The Markets Daily

Greenup Street Wealth Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1,108.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,927 shares of the medical equipment provider’s stock after purchasing an additional 6,354 shares during the period. Greenup Street Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,817,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in ISRG. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Intuitive Surgical in the 2nd quarter worth about $14,316,000. Plato Investment Management Ltd bought a new stake in Intuitive Surgical in the 2nd quarter valued at about $4,315,000. Hikari Power Ltd bought a new stake in Intuitive Surgical in the 2nd quarter valued at about $5,619,000. NewEdge Advisors LLC grew its position in shares of Intuitive Surgical by 19.1% during the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock worth $20,212,000 after purchasing an additional 8,142 shares in the last quarter. Finally, Nykredit A S acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $48,464,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the sale, the vice president directly owned 1,026 shares in the company, valued at $464,993.46. This represents a 79.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the sale, the director directly owned 1,204,530 shares in the company, valued at $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 38,778 shares of company stock worth $16,814,967 over the last quarter. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $432.01 on Friday. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The company has a market cap of $149.75 billion, a P/E ratio of 52.24, a P/E/G ratio of 3.09 and a beta of 1.46. The firm has a 50 day simple moving average of $401.54 and a two-hundred day simple moving average of $434.05.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter last year, the business posted $2.40 EPS. The company’s revenue was up 21.7% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ISRG. BTIG Research reaffirmed a “buy” rating and set a $454.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. Royal Bank Of Canada cut their price target on Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. Wells Fargo & Company reissued an “overweight” rating and set a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Evercore set a $430.00 price target on Intuitive Surgical in a research report on Monday, July 6th. Finally, Citigroup lowered their price objective on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Get Our Latest Stock Report on Intuitive Surgical

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).